Department of Biotechnology, Jamia Hamdard, New Delhi 110062, India.
CNR-IC, Area della Ricerca di RM1, Via Salaria km 29.3, Monterotondo, I-00015 Rome, Italy.
Sensors (Basel). 2024 Sep 23;24(18):6149. doi: 10.3390/s24186149.
Breast cancer stands as the most prevalent form of cancer amongst females, constituting more than one-third of all cancer cases affecting women. It causes aberrant cell development, which can assault or spread to other sections of the body, perhaps leading to the patient's death. Based on research findings, timely detection can diminish the likelihood of mortality and enhance the quality of healthcare provided for the illness. However, current technologies can only identify cancer at an advanced stage. Consequently, there is a substantial demand for rapid and productive approaches to detecting breast cancer. Researchers are actively pursuing precise and timely methods for the diagnosis of breast cancer, aiming to achieve enhanced accuracy and early detection. Biosensor technology can allow for the speedy and accurate diagnosis of cancer-related cells, as well as a more sensitive and specialized technique for generating them. Additionally, numerous treatments for breast cancer are depicted such as herbal therapy, nanomaterial-based drug delivery, miRNA targeting, CRISPR technology, immunotherapy, and precision medicine. Early detection and efficient therapy are necessary to manage such a severe illness properly.
乳腺癌是女性最常见的癌症类型，占所有女性癌症病例的三分之一以上。它导致异常细胞的发展，可能攻击或扩散到身体的其他部位，导致患者死亡。根据研究结果，及时发现可以降低死亡率的可能性，并提高对该疾病的医疗保健质量。然而，目前的技术只能在癌症晚期识别癌症。因此，对快速和高效的乳腺癌检测方法有很大的需求。研究人员正在积极寻求精确和及时的乳腺癌诊断方法，旨在提高准确性和早期检测。生物传感器技术可以快速准确地诊断与癌症相关的细胞，并且是生成这些细胞的更敏感和专业的技术。此外，还描述了许多乳腺癌的治疗方法，如草药疗法、基于纳米材料的药物输送、miRNA 靶向、CRISPR 技术、免疫疗法和精准医学。早期发现和有效的治疗是正确管理这种严重疾病的必要条件。
